Table 1: Characteristics and demographics of the study populations.

Jewish Arabs p
Total population 431,828 (70.1%) 184,510 (29.9%)
IBD patients 2,050 263
Prevalence 480/100.000 140/100.000 < 0.001
Age at diagnosis (y) 41.1 ± 18.8 35.6 ± 16.2 < 0.001
BMI 25.3 ± 6 25 ± 5.1 0.64
Male/Female 994 (48.5%)/1056 (51.5%) 131 (49.8%)/132 (50.2%) 0.68
CD/UC 1,070 (52%)/980 (48%) 134 (51%)/129 (49%) 0.7
Diabetes 224 (10.9%) 47 (17.9%) < 0.001
Dyslipidemia 789 (38.5%) 73 (27.8%) < 0.001
Lipid lowering drugs 338 (16.5%) 23 (8.7%) < 0.001
NSAID's use 591 (25.1%) 81 (30.8%) 0.5
Aspirin use 550 (26.8%) 66 (25.1%) 0.54

CD: Crohn's Disease, UC: Ulcerative Colitis, NSAIDS: Non-Steroidal Anti-Inflammatory Drugs.